NAJIBULRAHMAN SAIFULRAHMAN: Open Payments
NPI 1144517756 · SAN LEANDRO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$632 in 41 payments from 11 companies in 2025. Trend: 2023 $292 · 2024 $436 · 2025 $632
Food & beverage: $632
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $180 |
| Kowa Pharmaceuticals America, Inc. | 12 | $141 |
| Astellas Pharma US Inc | 4 | $74 |
| SCILEX PHARMACEUTICALS INC. | 3 | $58 |
| ABBVIE INC. | 2 | $45 |
| Lilly USA, LLC | 2 | $44 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| SHIELD THERAPEUTICS INC | 1 | $20 |
| Cipher Pharmaceuticals US LLC | 1 | $17 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
Products named: ZORYVE, Wegovy, Veozah, Ozempic, QULIPTA, ZTLido, JARDIANCE, AREXVY.
Industry payments across CA — which companies pay providers there.
